Breaking Barriers: Equitable Access To Clinical Trials & The Trial Modernization Act

The Equitable Access to Clinical Trials (EACT) initiative and the Clinical Trial Modernization Act (CTMA) aim to improve clinical trial inclusivity by addressing financial barriers to participation. EACT focuses on funding non-medical costs like travel and childcare to ensure financial neutrality for trial participants. Scout plays a key role in EACT, contributing to working groups that shape best practices and legal frameworks, while developing industry resources to guide sponsors in supporting participants financially. The CTMA's role in this change is to legislate broader financial support and technology-driven accessibility, removing logistical barriers and promoting trial inclusivity.

Together, EACT and CTMA lay the foundation for a future where clinical trials are equitable, accessible, and inclusive for all patients. Looking ahead, Scout continues to drive inclusivity in clinical trials through active participation in working groups, developing financial support practices, and collaborating with industry leaders. This ongoing commitment underscores Scout's strategy to make trials financially accessible and participant-friendly, paving the way for more representative and impactful clinical research.